Bare Financial Services’s Terns Pharmaceuticals TERN Stock Holding History

Bare Financial Services’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25	Closed	-$1.32K	–	1914
2026 Q1	$1.32K	Buy	25 +13	+108%	+$534	﹤0.01%	1139
2025 Q4	$485	Buy	+12	New	+$277	﹤0.01%	1430

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bare Financial Services's TERN Position: Q2 2026 in Review

Bare Financial Services sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 25 shares — an estimated $1.32K sold.

Bare Financial Services first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $1.32K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Bare Financial Services reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Bare Financial Services sold 25 Terns Pharmaceuticals shares in Q2 2026, an estimated $1.32K.
Bare Financial Services first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Bare Financial Services's Terns Pharmaceuticals position peaked at $1.32K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.